Central Bank & Trust Co. Sells 3,430 Shares of Clorox Co (CLX)

Central Bank & Trust Co. trimmed its stake in Clorox Co (NYSE:CLX) by 53.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,934 shares of the company’s stock after selling 3,430 shares during the quarter. Central Bank & Trust Co.’s holdings in Clorox were worth $436,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Nisa Investment Advisors LLC grew its holdings in shares of Clorox by 11.4% in the 4th quarter. Nisa Investment Advisors LLC now owns 55,076 shares of the company’s stock worth $8,192,000 after acquiring an additional 5,650 shares during the last quarter. Country Club Trust Company n.a. acquired a new position in shares of Clorox in the 4th quarter worth $253,000. Confluence Investment Management LLC grew its holdings in shares of Clorox by 1.7% in the 4th quarter. Confluence Investment Management LLC now owns 115,366 shares of the company’s stock worth $17,160,000 after acquiring an additional 1,976 shares during the last quarter. Private Asset Management Inc. acquired a new position in shares of Clorox in the 4th quarter worth $208,000. Finally, Parametric Portfolio Associates LLC grew its holdings in shares of Clorox by 3.9% during the third quarter. Parametric Portfolio Associates LLC now owns 536,640 shares of the company’s stock valued at $70,788,000 after buying an additional 20,303 shares in the last quarter. Institutional investors and hedge funds own 73.27% of the company’s stock.

A number of research analysts have recently weighed in on the company. Deutsche Bank assumed coverage on Clorox in a report on Wednesday, December 13th. They set a “hold” rating and a $142.00 price target on the stock. Royal Bank of Canada reiterated a “hold” rating and set a $115.00 price target on shares of Clorox in a report on Sunday, October 8th. Jefferies Group reiterated a “hold” rating and set a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price target on the stock in a report on Thursday, January 4th. Finally, Wells Fargo & Co reiterated a “hold” rating and set a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $134.33.

In related news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of Clorox stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by company insiders.

Clorox Co (NYSE:CLX) traded up $1.45 on Tuesday, reaching $142.41. The company had a trading volume of 867,418 shares, compared to its average volume of 840,220. The firm has a market capitalization of $18,360.00, a PE ratio of 26.13, a price-to-earnings-growth ratio of 3.69 and a beta of 0.42. Clorox Co has a 52-week low of $118.87 and a 52-week high of $150.40. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.36 earnings per share. research analysts forecast that Clorox Co will post 5.7 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.36%. Clorox’s payout ratio is 61.65%.

ILLEGAL ACTIVITY NOTICE: “Central Bank & Trust Co. Sells 3,430 Shares of Clorox Co (CLX)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/16/central-bank-trust-co-sells-3430-shares-of-clorox-co-clx.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply